TMEM43 and breast carcinoma: Globally, low expression of 16/17 genes correlated with poor relapse-free survival in luminal subtype breast cancer (11/17 with both subtypes, 2/17 only with LumB, 3/17 only with LumA, 1 discordant, Additional file 1: Figure S3).